Catalyst Wire Dossier Catalyst Wire Dossier

GSK576389A influenza vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GSK576389A influenza vaccine, covering 2012-05-30 to 2012-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults [Phase 2]

See pricing